MSPR vs CLVT

For growth investors, MSP Recovery, Inc.

(MSPR) is the stronger pick with 136. 8% revenue growth year-over-year, versus -4. 0% for Clarivate Plc (CLVT). Analysts rate Clarivate Plc (CLVT) a "Hold" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Clarivate Plc (CLVT) delivered a total return of -90.

0%, compared to -99. 8% for MSP Recovery, Inc. (MSPR). Over 10 years, the gap is even starker: CLVT returned -71. 0% versus MSPR's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Clarivate Plc (CLVT) is the lower-risk stock at 1.

22β versus MSP Recovery, Inc. 's 1. 33β — meaning MSPR is approximately 9% more volatile than CLVT relative to the S&P 500.

By revenue growth (latest reported year), MSP Recovery, Inc.

(MSPR) is pulling ahead at 136. 8% versus -4. 0% for Clarivate Plc (CLVT). On earnings-per-share growth, the picture is similar: Clarivate Plc grew EPS 68. 8% year-over-year, compared to -127. 8% for MSP Recovery, Inc.. Over a 3-year CAGR, MSPR leads at 7. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Clarivate Plc (CLVT) is the more profitable company, earning -8.

2% net margin versus -1975. 4% for MSP Recovery, Inc. — meaning it keeps -8. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLVT leads at 2. 9% versus -69. 8% for MSPR. At the gross margin level — before operating expenses — CLVT leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Clarivate Plc (CLVT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

22)). Both have compounded well over 10 years (CLVT: -71. 0%, MSPR: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MSPR (Healthcare) and CLVT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MSPR is a small-cap high-growth stock; CLVT is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.